[English] 日本語
Yorodumi- PDB-3ln3: Crystal structure of Putative reductase (NP_038806.2) from MUS MU... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 3ln3 | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal structure of Putative reductase (NP_038806.2) from MUS MUSCULUS at 1.18 A resolution | ||||||
Components | Dihydrodiol dehydrogenase | ||||||
Keywords | OXIDOREDUCTASE / Putative reductase / Structural Genomics / Joint Center for Structural Genomics / JCSG / Protein Structure Initiative / PSI-2 | ||||||
| Function / homology | Function and homology information: / Oxidoreductases; Acting on the CH-OH group of donors; With NAD+ or NADP+ as acceptor / xenobiotic metabolic process / oxidoreductase activity Similarity search - Function | ||||||
| Biological species | ![]() | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / SAD / Resolution: 1.18 Å | ||||||
Authors | Joint Center for Structural Genomics (JCSG) | ||||||
Citation | Journal: To be publishedTitle: Crystal structure of Putative reductase (NP_038806.2) from MUS MUSCULUS at 1.18 A resolution Authors: Joint Center for Structural Genomics (JCSG) | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 3ln3.cif.gz | 172 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb3ln3.ent.gz | 135.6 KB | Display | PDB format |
| PDBx/mmJSON format | 3ln3.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 3ln3_validation.pdf.gz | 784.5 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 3ln3_full_validation.pdf.gz | 788.4 KB | Display | |
| Data in XML | 3ln3_validation.xml.gz | 19.8 KB | Display | |
| Data in CIF | 3ln3_validation.cif.gz | 29.9 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/ln/3ln3 ftp://data.pdbj.org/pub/pdb/validation_reports/ln/3ln3 | HTTPS FTP |
-Related structure data
| Similar structure data | |
|---|---|
| Other databases |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| 2 | ![]()
| ||||||||
| Unit cell |
| ||||||||
| Details | CRYSTAL PACKING ANALYSIS SUPPORTS THE ASSIGNMENT OF A MONOMER AS THE SIGNIFICANT OLIGOMERIC FORM IN SOLUTION. |
-
Components
| #1: Protein | Mass: 38169.570 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| #2: Chemical | | #3: Chemical | ChemComp-NAD / | #4: Chemical | ChemComp-MRD / ( | #5: Water | ChemComp-HOH / | Has protein modification | Y | Sequence details | 1.THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED ...1.THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATI | |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.29 Å3/Da / Density % sol: 46.17 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, sitting drop / pH: 8 Details: 2.4000M ammonium sulfate, 0.1M TRIS pH 8.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 293K |
-Data collection
| Diffraction | Mean temperature: 100 K | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SSRL / Beamline: BL9-2 / Wavelength: 0.97931 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Detector | Type: MARMOSAIC 325 mm CCD / Detector: CCD / Date: Nov 5, 2009 / Details: Flat collimating mirror, toroid focusing mirror | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Radiation | Monochromator: Double crystal monochromator / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Radiation wavelength | Wavelength: 0.97931 Å / Relative weight: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reflection | Resolution: 1.18→28.895 Å / Num. obs: 110769 / % possible obs: 95 % / Observed criterion σ(I): -3 / Biso Wilson estimate: 7.922 Å2 / Rmerge(I) obs: 0.064 / Net I/σ(I): 6.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reflection shell |
|
-Phasing
| Phasing | Method: SAD |
|---|
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: SAD / Resolution: 1.18→28.895 Å / Cor.coef. Fo:Fc: 0.978 / Cor.coef. Fo:Fc free: 0.973 / Occupancy max: 1 / Occupancy min: 0.25 / SU B: 1.046 / SU ML: 0.021 / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R: 0.033 / ESU R Free: 0.033 Stereochemistry target values: MAXIMUM LIKELIHOOD WITH PHASES Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN ...Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 3.SULFATE (SO4) FROM THE CRYSTALLIZATION SOLUTION HAS BEEN MODELED IN THE SOLVENT STRUCTURE. 4.ENDOGENOUS NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD), WHICH IS THE EXPECTED COFACTOR FOR THIS PROTEIN, HAS BEEN MODELED AT THE PUTATIVE ACTIVE SITE. THE NAD SHOWS SOME DISORDER IN THE STRUCTURE. 5.(4R)-2-METHYLPENTANE-2,4-DIOL (MRD), WHICH MAY BE A SUBSTRATE MIMIC, HAS BEEN MODELED IN THE PUTATIVE ACTIVE SITE BASED ON THE ELECTRON DENSITY. HOWEVER, IT IS POSSIBLE THAT THIS MAY BE SOME OTHER COMPOUND. 6.THE PROTEIN WAS SUBJECTED TO REDUCTIVE METHYLATION PRIOR TO CRYSTALLIZATION. LYSINE 84 APPEARS TO HAVE BEEN PROTECTED FROM REDUCTIVE METHYLATION AND WAS MODELED AS LYSINE. ALL OTHER LYSINES HAVE BEEN MODELED AS N-DIMETHYL-LYSINE (MLY).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.4 Å / Solvent model: BABINET MODEL WITH MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 53.39 Å2 / Biso mean: 12.405 Å2 / Biso min: 3.79 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.18→28.895 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Resolution: 1.18→1.211 Å / Total num. of bins used: 20
|
Movie
Controller
About Yorodumi




X-RAY DIFFRACTION
Citation









PDBj








